m6A-centered Drug Response Information

General Information of the Drug (ID: M6APDG00812)
Name
1-(phenyl(p-tolyl)methylene)thiosemicarbazide
Synonyms
CHEMBL402465; 1-(phenyl(p-tolyl)methylene)thiosemicarbazide
    Click to Show/Hide
Status
Investigative
Structure
Formula
C15H15N3S
InChI
1S/C15H15N3S/c1-11-7-9-13(10-8-11)14(17-18-15(16)19)12-5-3-2-4-6-12/h2-10H,1H3,(H3,16,18,19)/b17-14+
InChIKey
DZOZYORQEZEOCT-SAPNQHFASA-N
PubChem CID
15722900
TTD Drug ID
D03JYN
Target Gene(s) and Their Upstream m6A Regulator, Together with the Effect of Target Gene(s) in Drug Response
The target genes involved in drug-target interaction (such as drug-metabolizing enzymes, drug transporters and therapeutic targets) and drug-mediated cell death signaling (including modulating DNA damage and repair capacity, escaping from drug-induced apoptosis, autophagy, cellular metabolic reprogramming, oncogenic bypass signaling, cell microenvironment, cell stemness, etc.) could be regulated by m6A regulator(s) and affected their corresponding drug response. You can browse detailed information on drug-related target gene(s) mediated by m6A regulators.
Cathepsin B (CTSB)
Fat mass and obesity-associated protein (FTO)
In total 1 mechanisms lead to this potential drug response
 Regulator Info 
Response Summary Cathepsin B (CTSB) is a therapeutic target for 1-(phenyl(p-tolyl)methylene)thiosemicarbazide. The Fat mass and obesity-associated protein (FTO) has potential in affecting the response of 1-(phenyl(p-tolyl)methylene)thiosemicarbazide through regulating the expression of Cathepsin B (CTSB). [1], [2]
References
Ref 1 A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors. Cell Res. 2018 Nov;28(11):1062-1076. doi: 10.1038/s41422-018-0097-4. Epub 2018 Oct 8.
Ref 2 Substrate optimization for monitoring cathepsin C activity in live cells. Bioorg Med Chem. 2009 Feb 1;17(3):1064-70. doi: 10.1016/j.bmc.2008.02.002. Epub 2008 Feb 7.